{"id":"https://openalex.org/W7225634848","doi":"https://doi.org/10.1002/der2.70101","title":"Psoriasis Through the Metabolic\u2010Inflammatory Axis: A Review of GLP\u20101 Agonists","display_name":"Psoriasis Through the Metabolic\u2010Inflammatory Axis: A Review of GLP\u20101 Agonists","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225634848","doi":"https://doi.org/10.1002/der2.70101"},"language":"en","primary_location":{"id":"doi:10.1002/der2.70101","doi":"https://doi.org/10.1002/der2.70101","is_oa":true,"landing_page_url":"https://doi.org/10.1002/der2.70101","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/der2.70101?download=true","source":{"id":"https://openalex.org/S4210204789","display_name":"Dermatological Reviews","issn_l":"2637-7489","issn":["2637-7489"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatological Reviews","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/der2.70101?download=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161335794","display_name":"Keya Shah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I4210143014","display_name":"Schweiger Dermatology Group (United States)","ror":"https://ror.org/03r4ey572","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143014"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keya Shah","raw_affiliation_strings":["Boston University Aram V. Chobanian & Edward Avedisian School of Medicine Boston Massachusetts USA","Skin Laser and Surgery Specialists: A Division of Schweiger Dermatology Group Hackensack New Jersey USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston University Aram V. Chobanian & Edward Avedisian School of Medicine Boston Massachusetts USA","institution_ids":["https://openalex.org/I111088046"]},{"raw_affiliation_string":"Skin Laser and Surgery Specialists: A Division of Schweiger Dermatology Group Hackensack New Jersey USA","institution_ids":["https://openalex.org/I4210143014"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084565314","display_name":"Barbara Kania","orcid":"https://orcid.org/0009-0003-4470-8836","observed_orcids":["https://orcid.org/0009-0003-4470-8836"]},"institutions":[{"id":"https://openalex.org/I4210143014","display_name":"Schweiger Dermatology Group (United States)","ror":"https://ror.org/03r4ey572","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143014"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara Kania","raw_affiliation_strings":["Skin Laser and Surgery Specialists: A Division of Schweiger Dermatology Group Hackensack New Jersey USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Skin Laser and Surgery Specialists: A Division of Schweiger Dermatology Group Hackensack New Jersey USA","institution_ids":["https://openalex.org/I4210143014"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019111228","display_name":"Ritvik Khandelwal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ritvik Khandelwal","raw_affiliation_strings":["University of Texas at Austin Austin TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas at Austin Austin TX","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004545282","display_name":"David J. Goldberg","orcid":"https://orcid.org/0000-0002-8950-439X","observed_orcids":["https://orcid.org/0000-0002-8950-439X"]},"institutions":[{"id":"https://openalex.org/I4210143014","display_name":"Schweiger Dermatology Group (United States)","ror":"https://ror.org/03r4ey572","country_code":"US","type":"company","lineage":["https://openalex.org/I4210143014"]},{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David J. Goldberg","raw_affiliation_strings":["Icahn School of Medicine at Mt. Sinai New York New York USA","Skin Laser and Surgery Specialists: A Division of Schweiger Dermatology Group Hackensack New Jersey USA"],"raw_orcid":"https://orcid.org/0000-0002-8950-439X","affiliations":[{"raw_affiliation_string":"Icahn School of Medicine at Mt. Sinai New York New York USA","institution_ids":["https://openalex.org/I98704320"]},{"raw_affiliation_string":"Skin Laser and Surgery Specialists: A Division of Schweiger Dermatology Group Hackensack New Jersey USA","institution_ids":["https://openalex.org/I4210143014"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3460,"currency":"USD","value_usd":3460},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"6","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12433","display_name":"Skin Diseases and Diabetes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9900000095367432},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9900000095367432},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.9829999804496765},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.8450000286102295},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.9919999837875366},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9959999918937683},{"id":"https://openalex.org/keywords/systemic-inflammation","display_name":"systemic inflammation","score":0.8600000143051147},{"id":"https://openalex.org/keywords/psoriasis-severity","display_name":"psoriasis severity","score":0.7549999952316284},{"id":"https://openalex.org/keywords/off-label-drug-use","display_name":"off-label drug use","score":0.5680000185966492}],"concepts":[{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.9142000079154968},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8476999998092651},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.48179998993873596},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4433000087738037},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.42719998955726624},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4049000144004822},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.3822999894618988},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.3702000081539154},{"id":"https://openalex.org/C2982889124","wikidata":"https://www.wikidata.org/wiki/Q107439039","display_name":"Disease management","level":4,"score":0.367900013923645},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.3626999855041504},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3564000129699707},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.3513000011444092},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3386000096797943},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.3208000063896179},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.30790001153945923},{"id":"https://openalex.org/C112446052","wikidata":"https://www.wikidata.org/wiki/Q422579","display_name":"Insulin receptor","level":4,"score":0.2921999990940094},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.2881999909877777},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.27900001406669617},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27810001373291016},{"id":"https://openalex.org/C2779231881","wikidata":"https://www.wikidata.org/wiki/Q5977147","display_name":"Medical literature","level":2,"score":0.2757999897003174},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.2687000036239624},{"id":"https://openalex.org/C140608501","wikidata":"https://www.wikidata.org/wiki/Q7318358","display_name":"Review article","level":2,"score":0.25099998712539673}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/der2.70101","doi":"https://doi.org/10.1002/der2.70101","is_oa":true,"landing_page_url":"https://doi.org/10.1002/der2.70101","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/der2.70101?download=true","source":{"id":"https://openalex.org/S4210204789","display_name":"Dermatological Reviews","issn_l":"2637-7489","issn":["2637-7489"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatological Reviews","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1002/der2.70101","doi":"https://doi.org/10.1002/der2.70101","is_oa":true,"landing_page_url":"https://doi.org/10.1002/der2.70101","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/der2.70101?download=true","source":{"id":"https://openalex.org/S4210204789","display_name":"Dermatological Reviews","issn_l":"2637-7489","issn":["2637-7489"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatological Reviews","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225634848.pdf","grobid_xml":"https://content.openalex.org/works/W7225634848.grobid-xml"},"referenced_works_count":51,"referenced_works":["https://openalex.org/W1896914803","https://openalex.org/W1981924240","https://openalex.org/W2001009396","https://openalex.org/W2017957916","https://openalex.org/W2021018799","https://openalex.org/W2032840557","https://openalex.org/W2054074756","https://openalex.org/W2067973725","https://openalex.org/W2070835847","https://openalex.org/W2170740909","https://openalex.org/W2341137663","https://openalex.org/W2612119351","https://openalex.org/W2742484040","https://openalex.org/W2779843551","https://openalex.org/W2795481136","https://openalex.org/W2899183711","https://openalex.org/W2924895007","https://openalex.org/W2942490664","https://openalex.org/W2981111930","https://openalex.org/W2995700701","https://openalex.org/W3028355101","https://openalex.org/W3123676674","https://openalex.org/W3128717870","https://openalex.org/W3150424981","https://openalex.org/W3205539519","https://openalex.org/W3216061490","https://openalex.org/W4200402944","https://openalex.org/W4206503891","https://openalex.org/W4211077900","https://openalex.org/W4280612747","https://openalex.org/W4285743594","https://openalex.org/W4306848286","https://openalex.org/W4319031878","https://openalex.org/W4384700736","https://openalex.org/W4389030365","https://openalex.org/W4391994515","https://openalex.org/W4392582405","https://openalex.org/W4394989398","https://openalex.org/W4400140876","https://openalex.org/W4402111022","https://openalex.org/W4403798856","https://openalex.org/W4404343992","https://openalex.org/W4406979066","https://openalex.org/W4409089068","https://openalex.org/W4410008879","https://openalex.org/W4410083173","https://openalex.org/W4414515790","https://openalex.org/W4415285461","https://openalex.org/W4416440937","https://openalex.org/W4416452249","https://openalex.org/W7122676412"],"related_works":["https://openalex.org/W7140310239","https://openalex.org/W7225455344","https://openalex.org/W4413348950","https://openalex.org/W7166838688","https://openalex.org/W7215043942","https://openalex.org/W2150108462","https://openalex.org/W4411786336","https://openalex.org/W7158361163","https://openalex.org/W7168051521","https://openalex.org/W4413893362"],"abstract_inverted_index":{"ABSTRACT":[0],"Background":[1],"Psoriasis":[2],"is":[3,485],"a":[4,42,265,452],"chronic":[5],"inflammatory":[6,89,326,413],"skin":[7],"disease":[8,262],"that":[9,145,278,365],"frequently":[10],"coexists":[11],"with":[12,119,124,236,256,291,338,378,425,468],"metabolic":[13,126,238,272,292,302,379,389],"disorders,":[14],"including":[15,240,479],"obesity":[16],"and":[17,54,83,107,129,143,165,185,187,194,206,222,246,304,319,347,391,406,434,460,481,492],"insulin":[18,241,471],"resistance.":[19],"In":[20],"recent":[21],"years,":[22],"glucagon\u2010like":[23],"peptide\u20101":[24],"(GLP\u20101)":[25],"receptor":[26,112,151,219,280,367,457],"agonists":[27,80,113,152,253,281,311,368,398,498],"have":[28,283,370],"become":[29],"increasingly":[30],"prevalent.":[31],"An":[32],"American":[33],"Medical":[34],"Association":[35],"analysis":[36],"of":[37,78,110,117,149,160,260,496],"national":[38],"claims":[39],"data":[40],"reported":[41],"greater":[43],"than":[44],"500%":[45],"increase":[46],"in":[47,88,114,153,258,286,307,336,342,373,394,423,429,462],"spending":[48],"on":[49,197,228,325,412],"GLP\u20101":[50,79,111,150,218,252,279,310,366,397,456,497],"medications":[51],"between":[52,141,217,301,388,455],"2018":[53],"2023,":[55],"from":[56],"$13.7":[57],"billion":[58],"to":[59,73,102,122,136,313,400,487],"$71.7":[60],"billion,":[61],"demonstrating":[62],"the":[63,75,104,115,147,249,299,351,355,386,438,442,489],"rapidly":[64],"increasing":[65],"demand":[66],"for":[67,333,357,420,444,499],"these":[68],"therapies.":[69],"As":[70,309,396],"research":[71],"continues":[72],"expand":[74],"potential":[76,105,266,285,323,372,410],"applications":[77],"beyond":[81,269],"diabetes":[82],"weight":[84],"management,":[85],"their":[86,270,322,334,409,421],"role":[87,268],"diseases":[90],"such":[91],"as":[92],"psoriasis":[93,154,224,229,500],"warrants":[94],"further":[95,358,445],"investigation.":[96,360,447],"Aims":[97],"This":[98],"literature":[99,132,212,353,440],"review":[100,133],"aims":[101],"evaluate":[103],"indications":[106,495],"therapeutic":[108,267,284,371],"effects":[109,227,324,411],"management":[116],"psoriasis,":[118,287,374],"particular":[120],"attention":[121],"patients":[123,235,290,337,377,424,467],"coexisting":[125,237,469],"disorders.":[127],"Materials":[128],"Methods":[130],"A":[131],"was":[134],"conducted":[135],"identify":[137],"scholarly":[138],"sources":[139],"published":[140],"2000":[142],"2026":[144],"examined":[146],"use":[148,221,335,422,459],"management.":[155,501],"Search":[156],"terms":[157],"included":[158,179],"combinations":[159],"\u201cpsoriasis,\u201d":[161],"\u201cpsoriatic,\u201d":[162],"\u201cGLP\u20101,\u201d":[163],"\u201csemaglutide,\u201d":[164],"\u201cinflammatory":[166],"axis.\u201d":[167],"Studies":[168],"involving":[169],"animal":[170],"models":[171],"or":[172,473],"non\u2010English\u2010speaking":[173],"participants":[174],"were":[175,192,231,254],"excluded.":[176],"Eligible":[177],"studies":[178,191],"randomized":[180],"controlled":[181],"trials,":[182],"case":[183],"reports":[184],"reviews,":[186],"cohort":[188],"studies.":[189],"Included":[190],"synthesized":[193],"evaluated":[195],"based":[196],"study":[198,343,430],"design,":[199,344,431],"intervention,":[200],"validity,":[201],"safety":[202],"outcomes,":[203],"clinical":[204,359,446,483,494],"indications,":[205],"participant\u2010reported":[207],"outcomes.":[208,225],"Results":[209],"The":[210,275,294,362,381],"reviewed":[211,250],"demonstrated":[213],"an":[214,330,417],"overall":[215],"association":[216,454],"agonist":[220,458],"improved":[223],"Positive":[226],"severity":[230],"particularly":[232,288,375,465],"evident":[233],"among":[234,289,376,466],"conditions,":[239,321,408],"resistance,":[242,472],"type":[243,474],"2":[244,475],"diabetes,":[245],"obesity.":[247],"Across":[248],"studies,":[251,484],"associated":[255],"improvements":[257,296,383],"measures":[259,349,436],"psoriatic":[261,463],"severity,":[263],"suggesting":[264],"established":[271],"indications.":[273],"Discussion":[274,361],"findings":[276,363],"suggest":[277,364],"may":[282,297,328,369,384,415],"comorbidities.":[293,380],"observed":[295,382],"reflect":[298,385],"relationship":[300,387],"dysfunction":[303,390],"systemic":[305,392],"inflammation":[306,393],"psoriasis.":[308,339,395,426],"continue":[312,399],"be":[314,401],"investigated":[315,402],"across":[316,350,403,437],"metabolic,":[317,404],"cardiovascular,":[318,405],"renal":[320,407],"pathways":[327,414],"provide":[329,416],"additional":[331,418],"mechanism":[332,419],"However,":[340,427],"differences":[341,428],"patient":[345,432],"populations,":[346,433],"outcome":[348,435],"available":[352,439],"highlight":[354,441],"need":[356,443],"Conclusion":[448],"Current":[449],"evidence":[450],"demonstrates":[451],"strong":[453],"improvement":[461],"symptoms,":[464],"obesity,":[470],"diabetes.":[476],"Further":[477],"research,":[478],"larger":[480],"well\u2010controlled":[482],"needed":[486],"establish":[488],"efficacy,":[490],"safety,":[491],"appropriate":[493]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}